The EVERY Company Enhances Its Intellectual Property
The EVERY Company, a prominent innovator in protein ingredients, has recently secured a significant patent for its recombinant ovalbumin in the European Union. This development consolidates its position as a leader in crafting functional protein ingredients, paving the way for its growth and expansion within the global food tech landscape.
Patenting Achievements and Innovations
This new patent expands on EVERY's existing intellectual property portfolio, which already boasts patents in several countries, including the US, Finland, Germany, and Mexico. The newly granted European patent provides coverage for an ingredient composition that incorporates recombinant ovalbumin, a crucial protein derived from egg whites, responsible for the characteristics that make eggs such a versatile ingredient.
Importance of Ovalbumin
Recombinant ovalbumin represents a significant advancement in food technology. This protein accounts for a major portion of egg white content and is essential for various culinary applications, including foaming, binding, and gelling. It plays a vital role in numerous recipes, affecting food texture and stability.
Expanded Patent Scope and Applications
The granted patent encompasses various innovations, which include performance enhancements to wild type ovalbumin through specialized modifications. It also supports ovalbumin sourced from diverse avian species and produced using various production methods, including fermentation with yeast and fungi like Pichia and Aspergillus. This breadth of application makes it an exciting component for multiple food categories.
Versatile Food Applications
Every's patented recombinant ovalbumin can be integrated into a high range of food products, from bakery items to liquid eggs and even alternative meat products. The functional properties of the protein, such as springiness and foam stability, enhance the overall quality and consumer appeal of these foods.
Commercial Partnerships in Europe
Despite not having secured regulatory approval within the European Union yet, EVERY has announced significant commercial partnerships earlier this year with reputable European companies such as Grupo Palacios and the Unilever brand, The Vegetarian Butcher. These strategic alliances signify EVERY's commitment to advancing the circulation of its innovative products in competitive markets.
A Competitive Edge in Food Technology
Arturo Elizondo, the Co-Founder and CEO of EVERY, emphasizes the competitive advantage that their intellectual property estate provides. With over seven years of pioneering work in bio-equivalent egg protein using fermentation, EVERY holds a first-mover advantage that is difficult for competitors to match. The company aims to lead the market by being the first to introduce recombinant egg proteins widely.
The Future of EVERY
Arturo Elizondo states that EVERY is just beginning its journey in the food tech ecosystem and is focused on continuing its path of innovation. The EVERY Company aims to bring recombinant egg proteins into mass production, showing their commitment to revolutionizing protein ingredients through science and technology.
About THE EVERY COMPANY
Located in San Francisco, EVERY™ is on a determined mission to create a more sustainable and accessible food system. By providing bio-equivalent protein ingredients produced via precision fermentation, the company is transforming traditional protein sourcing.
Among their innovative offerings are OvoPro™, which serves as a functional egg white replacement in many food applications, and OvoBoost™, a versatile protein additive designed to enhance the nutritional profile of various beverages and food products.
To explore more about how EVERY is changing the food industry landscape, interested parties can visit EVERY.com.
Frequently Asked Questions
What is recombinant ovalbumin?
Recombinant ovalbumin is a protein derived from egg whites that has been genetically engineered to enhance its functionality in various food applications.
How does the new patent impact EVERY's business?
The new European patent strengthens EVERY's intellectual property portfolio and supports its position in the competitive food tech market.
What are the potential applications of recombinant ovalbumin?
Recombinant ovalbumin can be used in bakery products, liquid eggs, alternative meats, and various other food formats to improve texture and stability.
Is EVERY currently seeking regulatory approval in Europe?
No, while EVERY is pushing forward with commercial partnerships, it has not yet obtained regulatory approval for its products in the European Union.
Where can I learn more about EVERY's products?
You can visit EVERY.com for detailed information about their innovative protein ingredients and B2B solutions.
